Home
Alkermes ALKS paid Splitoak Strategies $60K for lobbying in Q2 2026 · Medicare
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q2 2026
- Stock
- Alkermes ALKS
- Client
- Alkermes
- Reported
- 26/08/03
Up 0.0% from last quarter
What else happened in Alkermes around then
Filed or reported within 30 days of the trade day · 05/31~07/30Alkermes's other lobbying reports
- Alkermes
LobbyingAlkermes
LobbyingAlkermes
ALKS
Under $5,000
Under $5,000
Reported 09/15
for Q2
- Alkermes
LobbyingAlkermes
LobbyingAlkermes
ALKS
$60K
$60K
Reported 07/20
for Q2
- Alkermes
LobbyingAlkermes
LobbyingAlkermes
ALKS
$50K
$50K
Reported 07/20
for Q2
- Alkermes
LobbyingAlkermes
LobbyingAlkermes
ALKS
$930K
$930K
Reported 07/20
for Q2
- Alkermes
LobbyingAlkermes
LobbyingAlkermes
ALKS
$90K
$90K
Reported 07/20
for Q2